Today's news and events

Market

Earnings

PRIMAGREarnings

Prima Agro Ltd consolidated sales up 0.73% on year in Q2FY2027, net profit jumped 42.11%

Prima Agro Ltd share price slipped 0.99% to Rs 14.05. The Company's net profit saw a strong growth of 42.11% to Rs 0.27 crore, while revenue from operations slightly gained 0.73% to Rs 2.76 crore in Q2FY27 over Q2FY26. The market capitalization of Other Agricultural Products industry group stocks on BSE stood at Rs 58622.01 crore, slipping 0.18%. It has inched up 1.01% over last one week and edged lower by 2.02% in last one month while the market capitalization of Prima Agro Ltd has eased by 4.58% and 11.85% in the same period respectively. Profit before tax (PBT) of Prima Agro Ltd stood at Rs 0.37 crore in Q2 FY27, crashing by 17.78% year-on-year, and jumping 48.00% quarter-on-quarter. EBITDA came in at Rs 0 crore, declining 9.30% YoY and rallying 69.57% sequentially. Total expenses softened by 4.63% to Rs 2.47 crore in Q2FY27 over Q2FY26. During the quarter, employee benefits expense was at Rs 1.06 crore, surging 39.47% YoY. For FY26, revenue from operations inched higher 3.56% to Rs 10.47 crore, while net profit witnessed a sharp fall of 86.67% to Rs 0.06 crore, compared to previous FY. EBITDA tanked by 352% to Rs 1.59 crore, and PBT collapsed by 92.31% to Rs 0.02 crore compared to previous FY. The company's consolidated net cash flow from operating activities stood at Rs 0.55 crore in FY26, as against Rs 0.97 crore in FY25. Prima Agro Ltd nosedived by 35.49% in last one year, underperforming the benchmark BSE Sensex which has eased by 2.37% during the same period.

20 minutes agoCapital Market - Live

Interim 2 • Dividend/Share : ₹3.25

Earnings

PREMEXPLNEarnings

Premier Explosives Ltd consolidated sales up 41.65% on year in Q2FY2027, net profit soared by 289.61%

Premier Explosives Ltd share price rose by 5.53% to Rs 544.45 after the company's net profit saw a strong growth of 289.61% to Rs 12.0 crore, while revenue from operations gained significantly 41.65% to Rs 145.28 crore in Q2FY27 over Q2FY26. The market capitalization of Explosives industry group stocks on BSE stood at Rs 1.88 lakh crore, declining 3.55%. It has improved by 2.34% over last one week and softened by 4.69% in last one month while the market capitalization of Premier Explosives Ltd has marginally improved by 4.11% and 16.49% in the same period respectively. Profit before tax (PBT) of Premier Explosives Ltd stood at Rs 16.23 crore in Q2 FY27, nosediving by 34.29% year-on-year, and surging by 290.14% quarter-on-quarter. EBITDA came in at Rs 15 crore, tumbling by 188.54% YoY and rallying 258.05% sequentially. Total expenses surged 31.60% to Rs 131.02 crore in Q2FY27 over Q2FY26. During the quarter, cost of materials consumed stood at Rs 89.7 crore, rising 14.68% YoY, while employee benefits expense was at Rs 18.86 crore, remaining flat YoY. For FY26, revenue from operations declined slightly by 6.97% to Rs 388.34 crore, while net profit jumped 59.48% to Rs 45.82 crore, compared to previous FY. EBITDA witnessed a strong improvement of 5508% to Rs 3.5 crore, and PBT soared 60.03% to Rs 60.49 crore compared to previous FY. The company's consolidated net cash flow from operating activities stood at Rs 1.27 crore in FY26, as against Rs 118.48 crore in FY25. Premier Explosives Ltd fell 7.27% in last one year, significantly underperforming the benchmark BSE Sensex which has slipped by 2.37% during the same period.

20 minutes agoCapital Market - Live

Earnings

VIVOBIOTEarnings

Vivo Bio Tech Ltd consolidated sales up 20.38% on year in Q2FY2027, net profit jumped 478.95%

Vivo Bio Tech Ltd share price softened by 4.73% to Rs 14.11. The Company's net profit saw a strong growth of 478.95% to Rs 1.1 crore, while revenue from operations increased sharply by 20.38% to Rs 17.19 crore in Q2FY27 over Q2FY26. The market capitalization of Biotechnology industry group stocks on BSE stood at Rs 53928.9 crore, surging by 26.78%. It has inched up 4.20% over last one week and ticked higher by 7.16% in last one month while the market capitalization of Vivo Bio Tech Ltd has slipped by 4.80% and 29.80% in the same period respectively. Profit before tax (PBT) of Vivo Bio Tech Ltd stood at Rs 1.87 crore in Q2 FY27, jumping 23.84% year-on-year, and rallying 450.00% quarter-on-quarter. EBITDA came in at Rs 5 crore, retreating 14.20% YoY and declining 9.22% sequentially. Total expenses advancing by 16.46% to Rs 14.86 crore in Q2FY27 over Q2FY26. During the quarter, employee benefits expense was at Rs 4.87 crore, inching up 2.96% YoY. For FY26, revenue from operations rose 14.27% to Rs 53.33 crore, while net profit plunged by 123.49% to Rs 1.71 crore, compared to previous FY. EBITDA jumped by 1632% to Rs 21.01 crore, and PBT collapsed by 45.28% to Rs 4.81 crore compared to previous FY. The company's consolidated net cash flow from operating activities stood at Rs 34.93 crore in FY26, as against Rs 11.83 crore in FY25. Vivo Bio Tech Ltd nosedived by 56.78% in last one year, underperforming the benchmark BSE Sensex which has slipped by 2.37% during the same period.

20 minutes agoCapital Market - Live

See All

NIFTY 50		25,299.350.18%
USD/INR		94.130.27%
Gold		14,005.112.27%

NIFTY 100 Largecap		26,253.300.14%
NIFTY 100 Midcap		62,038.150.85%
NIFTY 100 Smallcap		19,720.251.16%

NIFTY Bank		61,518.501.19%
NIFTY IT		32,163.550.41%
NIFTY Pharma		28,682.300.33%

STOCKSPRICECHANGE
Lodha Developers LtdLODHA	₹1,226.004.38%
HDFC Life Insurance Company LtdHDFCLIFE	₹597.804.23%
DLF LtdDLF	₹769.303.59%
Shriram Finance LimitedSHRIRAMFIN	₹1,003.803.58%
Bajaj Finance LtdBAJFINANCE	₹1,115.003.36%

FUNDSRETURNS
Taurus Large Cap Fund Equity • Growth 12.66%
Quant Large Cap Fund Equity • Growth 7.39%
Invesco India Largecap Fund Equity • Growth 7.13%
Bank of India Large Cap Fund Equity • Growth 5.54%
Bandhan Large Cap Fund Equity • Growth 4.26%

Tickertape - Financial freedom begins here

Market and sectors

Today's stocks

Mutual funds and ETFs

Ready-made Portfolios

Curated screens and deals

Stock Screens

Deals

Mutual Fund Screens